Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark G Jones

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Environment International|July 7, 2026
Ultrafine particulate matter emitted from ships drives inflammation and susceptibility to viral infectionNatasha H C Easton, Lareb S N Dean, James G H Parkin, et al.
The European Respiratory Journal|November 16, 2023
Mortality surrogates in combined pulmonary fibrosis and emphysemaAn Zhao, Eyjolfur Gudmundsson, Nesrin Mogulkoc, et al.
BMJ Open Respiratory Research|September 24, 2021
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)Jim M Wild, Joanna C Porter, Philip L Molyneaux, et al.
Ebiomedicine|January 25, 2026
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injuryIain Stewart, Joseph Jacob, Joanna C Porter, et al.
ERJ Open Research|January 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UKGiles Dixon, Samuel Hague, Sarah Mulholland, et al.
The Lancet. Respiratory Medicine|April 18, 2023
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort studyCallum Jackson, Iain D Stewart, Tatiana Plekhanova, et al.
American Journal of Respiratory and Critical Care Medicine|December 2, 2022
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 StudyIain Stewart, Joseph Jacob, Peter M George, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Environment International|July 7, 2026
Ultrafine particulate matter emitted from ships drives inflammation and susceptibility to viral infectionNatasha H C Easton, Lareb S N Dean, James G H Parkin, et al.
The European Respiratory Journal|November 16, 2023
Mortality surrogates in combined pulmonary fibrosis and emphysemaAn Zhao, Eyjolfur Gudmundsson, Nesrin Mogulkoc, et al.
BMJ Open Respiratory Research|September 24, 2021
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)Jim M Wild, Joanna C Porter, Philip L Molyneaux, et al.
Ebiomedicine|January 25, 2026
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injuryIain Stewart, Joseph Jacob, Joanna C Porter, et al.
ERJ Open Research|January 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UKGiles Dixon, Samuel Hague, Sarah Mulholland, et al.
The Lancet. Respiratory Medicine|April 18, 2023
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort studyCallum Jackson, Iain D Stewart, Tatiana Plekhanova, et al.
American Journal of Respiratory and Critical Care Medicine|December 2, 2022
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 StudyIain Stewart, Joseph Jacob, Peter M George, et al.
Pageof 6